TGF-β1-regulated miR-3691-3p targets E2F3 and PRDM1 to inhibit prostate cancer progression

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Transforming growth factor-β1 (TGF-β1) is a known tumor promoter in advanced prostate cancer (PCa).
• MicroRNAs (miRNAs) inhibited by TGF-β1 may possess anti-tumor properties.
• Identifying novel regulatory pathways is crucial for understanding PCa progression.

Purpose of the Study:

• To investigate the role of TGF-β1-regulated miRNAs in prostate cancer.
• To identify and characterize specific miRNAs with potential anti-oncogenic functions in PCa.
• To elucidate the molecular mechanisms underlying the anti-tumor effects of identified miRNAs.

Main Methods:

• Screening of miRNAs downregulated by TGF-β1 in PCa cell lines.
• Expression analysis of miR-3691-3p in clinical PCa tissues.
• Functional assays (overexpression, silencing) in PCa cell lines to assess proliferation, migration, invasion, and apoptosis.
• In vivo studies using PCa xenograft mouse models.
• Target gene identification and validation (E2F3, PRDM1).

Main Results:

• miR-3691-3p expression was significantly lower in PCa tissues and inversely correlated with aggressive features.
• Overexpression of miR-3691-3p inhibited PCa cell proliferation, migration, and invasion, while promoting apoptosis.
• miR-3691-3p directly targets and downregulates E2F3 and PRDM1, which are overexpressed in PCa.
• Inhibition of E2F3 or PRDM1 mimicked the anti-tumor effects of miR-3691-3p.
• In vivo administration of a miR-3691-3p agomir suppressed tumor growth and induced apoptosis in xenograft models.

Conclusions:

• TGF-β1-regulated miR-3691-3p functions as a tumor suppressor in prostate cancer.
• miR-3691-3p exerts its anti-oncogenic effects by downregulating E2F3 and PRDM1.
• This study reveals a novel mechanism by which TGF-β1 promotes PCa progression via suppression of miR-3691-3p.